These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 24134122

  • 1. Synthesis and characterization of lipid immuno-nanocapsules for directed drug delivery: selective antitumor activity against HER2 positive breast-cancer cells.
    Sánchez-Moreno P, Ortega-Vinuesa JL, Boulaiz H, Marchal JA, Peula-García JM.
    Biomacromolecules; 2013 Dec 09; 14(12):4248-59. PubMed ID: 24134122
    [Abstract] [Full Text] [Related]

  • 2. Characterization of different functionalized lipidic nanocapsules as potential drug carriers.
    Sánchez-Moreno P, Ortega-Vinuesa JL, Martín-Rodríguez A, Boulaiz H, Marchal-Corrales JA, Peula-García JM.
    Int J Mol Sci; 2012 Dec 09; 13(2):2405-2424. PubMed ID: 22408461
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.
    Yang Z, Tang W, Luo X, Zhang X, Zhang C, Li H, Gao D, Luo H, Jiang Q, Liu J.
    J Biomed Nanotechnol; 2015 Aug 09; 11(8):1401-17. PubMed ID: 26295141
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL, Yakes FM, Muthuswamy SK, Bianco R, Simpson JF, Arteaga CL.
    Cancer Res; 2001 Dec 15; 61(24):8887-95. PubMed ID: 11751413
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and in vitro characterization of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]-trastuzumab conjugates targeted to breast cancer.
    Lee JH, Sabnis G, Nan A.
    Macromol Biosci; 2012 Jan 15; 12(1):55-60. PubMed ID: 22052593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells.
    Sánchez-Moreno P, Boulaiz H, Ortega-Vinuesa JL, Peula-García JM, Aránega A.
    Int J Mol Sci; 2012 Jan 15; 13(4):4906-4919. PubMed ID: 22606019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
    Ding B, Chen P, Kong Y, Zhai Y, Pang X, Dou J, Zhai G.
    J Drug Target; 2014 Jan 15; 22(1):67-75. PubMed ID: 24099639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.